Skip to content

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Mechanism-aware and explainable artificial intelligence for drug release prediction in polymeric drug delivery systems

Predicting drug release from polymer-based delivery systems remains challenging because release behavior depends on nonlinear interactions among formulation composition, polymer properties, drug characteristics, processing conditions, and time. This study develops an interpretable artificial intelligence framework for...

Mohammed Y. Ghazwani, Yahia Alghazwani, Umme Hani · 0 citations
Open access Aug 2026

Formulation and Optimization of Artemether-Loaded Nanoemulsions by Applying QbD

The optimized Artemether-loaded nanoemulsion developed using a Box–Behnken Design significantly enhanced the drug’s dissolution and exhibited favorable physicochemical characteristics, high entrapment efficiency, and controlled release behavior, suggesting that nanoemulsion is a promising carrier system warranting furt...

Yahya Alhamhoom, Umme Hani, Nagashubha Bobbarjang et al. · 0 citations
#artificial intelligence Open access Sep 2026

Mechanism-informed machine learning for interpretable drug release prediction and virtual formulation intervention in polymeric long-acting injectables

The correct time-course forecasting of the release of a drug contained in a drug-polymer matrix is difficult because drug dissolution is a complex process involving all formulation parameters, which are interdependent and have nonlinear effects. Although the predictive accuracy of machine learning (ML) models is high,...

Mohammed Y. Ghazwani, Yahia Alghazwani, Umme Hani · 0 citations
Aug 2026

One-Pot Synthesis of Naphthalen-2-Thiazolidinones as Potential Breast Cancer Therapeutics: An Integrative Approach Using Network Pharmacology, Biomolecular Simulations and in Vitro Evaluation

Overall, the moderate promising leads of NT1 and NT9 emerged with dual-target potential for breast cancer, supporting further optimization and preclinical assessment.

C. N. Babu, Mazin Aboobaida Abdalla Abdelaziz, N. Nizamuddin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.